APDN Submits PCR-based Monkeypox Diagnostic Test to NYS Dept of Health
August 19, 2022
Read More
Applied DNA Reports Third Quarter Fiscal 2022 Financial Results
August 11, 2022
First Successful Administration of LinearDNA via Lipid Nanoparticles
August 10, 2022
APDN Awarded Extension of Health Services Contract with CUNY
August 9, 2022
APDN Receives ~$3.6 Million in Net Proceeds from Warrant Exercise
APDN to Host Conference Call and Webcast Discussing FQ3’22 Results
August 8, 2022
APDN Announces Closing of $12M Upsized Public Offering
APDN Announces Pricing of $12M Upsized Public Offering
August 4, 2022
APDN Initiates Validation of PCR-based Monkeypox Diagnostic Test
August 2, 2022
Get Social